Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Nicolas Girard; F. Mornex; J.-Y. Douillard; Nadine Bossard; E. Quoix; V. Beckendorf; D. Grunenwald; E. Amour; B. Milleron

Journal articles

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Nicolas Girard F. Mornex J.-Y. Douillard Nadine Bossard ¹ E. Quoix V. Beckendorf D. Grunenwald E. Amour B. Milleron

1 Biostatistiques santé

Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Other [q-bio.OT]

Complete list of metadata

https://hal.archives-ouvertes.fr/hal-00539239
Contributor : Stéphane Delmotte Connect in order to contact the contributor
Submitted on : Wednesday, November 24, 2010 - 2:41:07 PM
Last modification on : Sunday, September 25, 2022 - 3:53:40 AM

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Identifiers

Collections

Citation

Export

Metrics

54

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Identifiers

Collections

Citation

Export

Share

Metrics

54